Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization

Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization

<i>Background and Objectives</i>: To assess the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) with oxaliplatin plus raltitrexed (HAICROX) as an alternative treatment option for advanced hepatocellular carcinoma (HCC) patients who are ineligible for, or failed, the...

Full description

Bibliographic Details
Main Authors: Yanfang Wu, Susu Zheng, Zhenzhen Zhang, Guobin Chen, Xiaochun Chen, Tanghui Zheng, Xinkun Guo, Hong Chen, Meixia Wang, Xiaoying Xie, Boheng Zhang
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Medicina
Subjects:
hepatic arterial infusion chemotherapy
hepatocellular carcinoma
transarterial chemoembolization
treatment failure
unsuitability
Online Access:https://www.mdpi.com/1648-9144/58/10/1343

Internet

https://www.mdpi.com/1648-9144/58/10/1343

Similar Items